期刊文献+

步长头痛宁胶囊治疗偏头痛临床观察

原文传递
导出
摘要 摘要:目的:观察采用步长头痛宁治疗偏头痛的临床效果。方法:选取我院在2008—2010年收治的86例偏头痛患者,其中男性48例,年龄在20一55岁之间,病程为3个月-10年,女性38例,年龄在18—60岁之间,病程为6个月-12年。86例患者中,风火型10例,风瘀型21例,风痰型16例,气血两虚型28例,阳虚寒凝型11例。将86例患者随机分为两组,观察组患者46例,对其采用步长头痛宁胶囊进行治疗,对照组患者40例,对其采用谷维素、安定、去痛片进行治疗,对两组患者的治疗效果进行观察分析。结果:经过一些列的治疗,两组患者的病情均有不同程度的好转,其中,观察组46例患者中,痊愈33例,显效7例,有效4例,无效2例,有效率迭95.7%,对照组40例患者患者中,痊愈22例,显效6例,有效5例,无效7例,有效率为82.5%,对两组患者的治疗效果进行分析比较,差异显著,观察组的治疗效果要显著优于对照组的治疗效果。结论:在治疗偏头痛痰病时,采用步长头痛宁胶囊治疗的效果较为显著,对于患者的病情有较大帮助,因此,值得在临床治疗偏头痛疾病中推广应用。
作者 马本仲
出处 《按摩与康复医学》 2012年第24期63-64,共2页 Chinese Manipulation and Rehabilitation Medicine
  • 相关文献

参考文献2

二级参考文献20

  • 1[1]Maini RN,Breedveld FC,Kalden JR,et al.Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis[J].Arthritis Rheum,1998,41:1552.
  • 2[2]Maini R,St Clair EW,Breedveld F,et al.Infliximab (chimeric antitumor necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate:randomized phase Ⅲ trial:attract study group[J].Lancet,1999,354:1932.
  • 3[3]St Clai EW,van der Heijde D,Smolen J,et al.Combination of infliximab and methotrexate therapy for early rheumatoid arthritis:a randomized,controlled trial[J].Arthritis Rheum,2004,50:3432.
  • 4[4]U Lange,J Teichmann,Mulle Ladner U,et al.Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-antibody:a prospective open-label pilot study[J].Rheumatology,2005,44:1546.
  • 5[5]PC Taylor,A Steuer,J Gruber,et al.Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one year delayed addition of Infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis[J].Arthritis rheumatism,2006,54:47.
  • 6[6]Carrasco R,Smith JA,Lovell D.Biologic agents for the treatment of juvenile rheumatoid arthritis:current status[J].Paediatr Drugs,2004,6:137.
  • 7[7]Gerloni V,Pontikaki I,Gattinara M,et al.Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody,infliximab,in persistently active,refractory juvenile idiopathic arthritis:results of an open-label prospective study[J].Arthritis Rheum,2005,52:548.
  • 8[8]Braun J,Brandt J,Listing J,et al.Treatment of active ankylosing spondylitis with infliximab:a randomized controlled multicentre trial[J].Lancet,2002,359:1187.
  • 9[9]Braun J,Brandt J,Listing J,et al.Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis[J].Ann Rheum Dis,2005,64:229.
  • 10[10]Braun J,Baraliakos X,Brandt J,et al.Persistant clinical response to the anti-TNF alpha antibody infiiximab in patients with anylosing spondylitis over 3 years[J].Rheumatology,2005,44:670.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部